Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
3.140
+0.140 (4.67%)
May 12, 2025, 4:00 PM - Market closed
Vivos Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$6.10
Upside
+94.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.6 → $6.2 | Strong Buy | Maintains | $6.6 → $6.2 | +97.45% | Apr 15, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $6.6 | Strong Buy | Reiterates | $6.6 | +110.19% | Nov 20, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $8.25 → $6 | Strong Buy | Maintains | $8.25 → $6 | +91.08% | Nov 19, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.4 → $6.6 | Strong Buy | Maintains | $6.4 → $6.6 | +110.19% | Aug 20, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $63 | Strong Buy | Initiates | $63 | +1,890.45% | Jan 17, 2023 |
| Roth Capital | Roth Capital | Strong Buy Maintains $275 → $250 | Strong Buy | Maintains | $275 → $250 | +7,861.78% | Aug 13, 2021 |
| Roth Capital | Roth Capital | Strong Buy Maintains $300 → $275 | Strong Buy | Maintains | $300 → $275 | +8,657.96% | May 18, 2021 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +9,454.14% | Jan 11, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +9,454.14% | Jan 5, 2021 |